Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Esophageal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Neoplasms 2Colonic Neoplasms 2Prostatic Neoplasms 1Pancreatic Cystic Neoplasms 1Melanoma 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Liver Cirrhosis 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophagogastric Cancer 1Endometrial Neoplasms 1Biliary Tract Neoplasms 1Anus Neoplasms 1

Interventions

zirconium-89-trastuzumab 1STA 9090 1Positron-Emission Tomography 1Pemetrexed 1Oxaliplatin 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophagogastric Cancer × Positron-Emission Tomography × Gastrointestinal × Clear all
NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
42 enrolled 11 charts
Gastrointestinal

Esophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡